// AST – IMS - [DMinute_ROS]

Pfizer (PFE) Shareholder Foundation Resource Management Decreased Its Stake as Share Value Rose; Ycg Lifted Its Lauder Estee Cos (EL) Position by $636,260; Share Price Declined

The Estée Lauder Companies Inc. (NYSE:EL) Logo

Ycg Llc increased its stake in Lauder Estee Cos Inc (EL) by 7.55% based on its latest 2018Q3 regulatory filing with the SEC. Ycg Llc bought 4,388 shares as the company’s stock declined 0.41% with the market. The institutional investor held 62,474 shares of the consumer non-durables company at the end of 2018Q3, valued at $9.08 million, up from 58,086 at the end of the previous reported quarter. Ycg Llc who had been investing in Lauder Estee Cos Inc for a number of months, seems to be bullish on the $45.53B market cap company. The stock decreased 1.84% or $2.35 during the last trading session, reaching $125.48. About 2.52M shares traded or 8.36% up from the average. The Estée Lauder Companies Inc. (NYSE:EL) has risen 10.23% since January 10, 2018 and is uptrending. It has outperformed by 10.23% the S&P500. Some Historical EL News: 19/03/2018 – Colgate-Palmolive (CL), Estee Lauder (EL) on Watch Amid Rumors; 02/05/2018 – Estee Lauder 3Q EPS Boosted 11c by Forex; 20/04/2018 – North Bluff Capital: $EL $GOOGL EXCLUSIVE: Karlie Kloss’ Lauder Deal Goes Deeper Than Typical Partnership; 25/04/2018 – ESTEE LAUDER SAYS PAID PARENTAL LEAVE POLICY EXPANDED TO 20 WKS; 02/05/2018 – ESTEE LAUDER SEES FY ADJ EPS $4.38 TO $4.42, EST. $4.37; 02/05/2018 – The Estée Lauder Companies Fiscal 2018 Third Quarter Sales Growth of 18% Drives 24% EPS Increase; 14/05/2018 – ESTEE LAUDER COMPANIES INC EL.N : MORGAN STANLEY RAISES TARGET PRICE TO $162 FROM $153; 23/03/2018 – ESTEE LAUDER SEES PRETAX RESTRUCTURING CHARGES OF ABOUT $93M; 02/05/2018 – Estee Lauder Maintains Momentum as Sales Rise for Fifth Quarter; 16/04/2018 – ESTEE LAUDER COMPANIES SAYS ON APRIL 16, BOARD OF CO INCREASED ITS SIZE TO 17 MEMBERS – SEC FILING

Foundation Resource Management Inc decreased its stake in Pfizer (PFE) by 28.13% based on its latest 2018Q3 regulatory filing with the SEC. Foundation Resource Management Inc sold 210,923 shares as the company’s stock rose 5.56% while stock markets declined. The institutional investor held 538,918 shares of the health care company at the end of 2018Q3, valued at $23.75 million, down from 749,841 at the end of the previous reported quarter. Foundation Resource Management Inc who had been investing in Pfizer for a number of months, seems to be less bullish one the $244.40 billion market cap company. The stock decreased 2.45% or $1.06 during the last trading session, reaching $42.28. About 21.68 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 25.07% since January 10, 2018 and is uptrending. It has outperformed by 25.07% the S&P500. Some Historical PFE News: 16/05/2018 – STAT Plus: Pharmalittle: Former Novartis CEO regrets Cohen contract as top lawyer resigns; Pfizer wins biosimilar approval; 11/04/2018 – PFIZER INC PFE.N : BERENBERG RAISES TARGET PRICE TO $37 FROM $36; 10/04/2018 – PFIZER INC – IN TRIAL, NO NEW SAFETY SIGNALS WERE OBSERVED, AND SAFETY PROFILE WAS CONSISTENT WITH KNOWN PROFILE OF INLYTA IN ADVANCED RCC; 17/04/2018 – Merck Announces First Phase Three Studies for PCV-15 (V114) Its Investigational Pneumococcal Disease Vaccine; 15/05/2018 – Enclara Pharmacia Inks Five-Year Contract Extension with VITAS Healthcare, Continues Highest Service Levels for Patient Medication Management; 01/05/2018 – Pfizer Sales Disappoint as Investors Wait for Strategic M&A; 17/05/2018 – FDA’S GOTTLIEB – COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE PHARMACIA AND UPJOHN CO, QUESTCOR PHARMACEUTICALS, BOEHRINGER INGELHEIM, NPS PHARMA; 23/03/2018 – PFIZER CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES; 07/03/2018 – CYTOMX THERAPEUTICS – ON MARCH 6, CO RECEIVED NOTIFICATION OF PFIZER’S INTENT TO TERMINATE THEIR 2013 RESEARCH COLLABORATION, OPTION, LICENSE AGREEMENT; 20/04/2018 – Pfizer Bond Trading 2x Average; Clients Net Buyers

Investors sentiment increased to 0.85 in 2018 Q3. Its up 0.07, from 0.78 in 2018Q2. It is positive, as 41 investors sold PFE shares while 741 reduced holdings. 142 funds opened positions while 520 raised stakes. 3.96 billion shares or 0.44% less from 3.98 billion shares in 2018Q2 were reported. Martin And Tn stated it has 0.62% in Pfizer Inc. (NYSE:PFE). Signature And Invest Advisors Ltd Limited Liability Company invested in 4,944 shares. Montag A & stated it has 211,941 shares or 0.82% of all its holdings. Pinnacle Associates accumulated 0.62% or 678,123 shares. Parkside Fincl Bank has invested 0.56% in Pfizer Inc. (NYSE:PFE). Fort Point Prtn Limited Company holds 0.17% in Pfizer Inc. (NYSE:PFE) or 12,684 shares. Fiduciary Fincl Service Of The Southwest Inc Tx accumulated 171,111 shares or 2.1% of the stock. Iberiabank invested 0.73% in Pfizer Inc. (NYSE:PFE). Greenwood Associates Ltd Liability holds 1.57% or 163,808 shares in its portfolio. Buckhead Capital Mgmt Ltd Liability Corporation invested in 222,943 shares or 3.01% of the stock. Lehman Finance Resource holds 197,344 shares or 4.08% of its portfolio. Segall Bryant & Hamill Llc reported 1.22M shares. Campbell Newman Asset Management invested in 0.27% or 42,711 shares. Ascend Lc holds 0.06% or 25,782 shares. Mogy Joel R Counsel stated it has 0.84% in Pfizer Inc. (NYSE:PFE).

Among 23 analysts covering Pfizer (NYSE:PFE), 8 have Buy rating, 1 Sell and 14 Hold. Therefore 35% are positive. Pfizer had 89 analyst reports since July 29, 2015 according to SRatingsIntel. BMO Capital Markets maintained it with “Buy” rating and $37.0 target in Tuesday, September 5 report. Piper Jaffray maintained Pfizer Inc. (NYSE:PFE) rating on Friday, August 28. Piper Jaffray has “Overweight” rating and $48 target. On Tuesday, January 16 the stock rating was maintained by Jefferies with “Hold”. The rating was maintained by Bank of America with “Buy” on Wednesday, August 1. The rating was maintained by Deutsche Bank with “Buy” on Wednesday, October 28. On Wednesday, November 1 the stock rating was maintained by UBS with “Buy”. The firm has “Buy” rating by Argus Research given on Tuesday, November 3. The stock has “Neutral” rating by Credit Suisse on Wednesday, January 31. The firm earned “Market Perform” rating on Wednesday, November 2 by BMO Capital Markets. The rating was maintained by Cowen & Co with “Buy” on Monday, September 18.

Since July 20, 2018, it had 0 insider buys, and 2 sales for $1.92 million activity. $1.50M worth of Pfizer Inc. (NYSE:PFE) shares were sold by SUSMAN SALLY.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on January, 29 before the open. They expect $0.64 EPS, up 3.23% or $0.02 from last year’s $0.62 per share. PFE’s profit will be $3.70B for 16.52 P/E if the $0.64 EPS becomes a reality. After $0.78 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -17.95% negative EPS growth.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Streetinsider.com which released: “Pfizer (PFE) Begins Phase 2b/3 Clinical Trial for PF-06651600 for Treatment of Patients with Moderate to Severe Alopecia Areata – StreetInsider.com” on January 03, 2019, also Streetinsider.com with their article: “Pfizer (PFE) Phase 2b STRIVE Clinical Trial of Staphylococcus aureus Vaccine Discontinued Due to Futility – StreetInsider.com” published on December 20, 2018, Fool.com published: “3 Reasons Why Pfizer’s Latest Dividend Hike Is Better Than You Might Think – The Motley Fool” on December 18, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Seekingalpha.com and their article: “Pfizer, Merck cancel avelumab study – Seeking Alpha” published on December 21, 2018 as well as Investorplace.com‘s news article titled: “7 Dow Jones Stocks Set to Charge Higher – Investorplace.com” with publication date: January 09, 2019.

Since August 22, 2018, it had 0 insider purchases, and 21 sales for $64.72 million activity. On Tuesday, November 6 the insider TRAVIS TRACEY THOMAS sold $1.05 million. Another trade for 19,077 shares valued at $2.69M was sold by Freda Fabrizio. LAUDER RONALD S FOUNDATION also sold $2.19 million worth of The Estée Lauder Companies Inc. (NYSE:EL) on Wednesday, August 29. Haney Carl P. sold $1.82 million worth of stock. $783,841 worth of The Estée Lauder Companies Inc. (NYSE:EL) was sold by O’HARE MICHAEL. Shares for $4.84 million were sold by LAUDER JANE on Thursday, August 23.

Investors sentiment decreased to 0.79 in Q3 2018. Its down 0.39, from 1.18 in 2018Q2. It turned negative, as 57 investors sold EL shares while 266 reduced holdings. 73 funds opened positions while 182 raised stakes. 187.38 million shares or 2.83% less from 192.84 million shares in 2018Q2 were reported. Guggenheim Cap Lc invested in 190,051 shares. Farmers Merchants Investments Incorporated holds 0% or 88 shares. 19,440 were accumulated by Commonwealth Bank Of Aus. Barclays Public Limited Company holds 0.04% or 362,000 shares. Dnb Asset As owns 29,026 shares. Tiedemann Advisors Ltd Liability Company, a New York-based fund reported 4,082 shares. Comgest Glob Invsts Sas stated it has 0.07% of its portfolio in The Estée Lauder Companies Inc. (NYSE:EL). Connecticut-based Columbus Circle has invested 0.87% in The Estée Lauder Companies Inc. (NYSE:EL). Utah Retirement Systems owns 0.11% invested in The Estée Lauder Companies Inc. (NYSE:EL) for 40,451 shares. National Asset Mngmt Inc reported 0.07% of its portfolio in The Estée Lauder Companies Inc. (NYSE:EL). Moreover, Agf has 0.31% invested in The Estée Lauder Companies Inc. (NYSE:EL) for 209,303 shares. 22,142 were accumulated by Sumitomo Mitsui Asset Mngmt Ltd. Winslow Evans Crocker holds 40 shares. 154,988 are owned by Sei Invs Company. Cypress Asset Management Tx has 0.3% invested in The Estée Lauder Companies Inc. (NYSE:EL).

More notable recent The Estée Lauder Companies Inc. (NYSE:EL) news were published by: Seekingalpha.com which released: “Kinder Morgan Targets Upside From 10,000 Mile Long Gas Pipeline – Seeking Alpha” on January 10, 2019, also 247Wallst.com with their article: “Top Analyst Upgrades and Downgrades: Bed Bath & Beyond, Boeing, Constellation, Dell, Dollar General, Lockheed Martin, NOV, Snap, Twitter, Yelp and More – 24/7 Wall St.” published on January 10, 2019, Investorplace.com published: “7 ‘Strong Buy’ Defensive Stocks For 2019 – Investorplace.com” on December 31, 2018. More interesting news about The Estée Lauder Companies Inc. (NYSE:EL) were released by: Benzinga.com and their article: “Benzinga’s Top Upgrades, Downgrades For January 2, 2019 – Benzinga” published on January 02, 2019 as well as Benzinga.com‘s news article titled: “Benzinga’s Top Upgrades, Downgrades For January 10, 2019 – Benzinga” with publication date: January 10, 2019.

Among 34 analysts covering Estee Lauder (NYSE:EL), 26 have Buy rating, 2 Sell and 6 Hold. Therefore 76% are positive. Estee Lauder had 129 analyst reports since July 21, 2015 according to SRatingsIntel. Stifel Nicolaus maintained The Estée Lauder Companies Inc. (NYSE:EL) rating on Friday, August 18. Stifel Nicolaus has “Buy” rating and $108.0 target. BMO Capital Markets maintained the stock with “Market Perform” rating in Thursday, November 2 report. The firm has “Outperform” rating by Macquarie Research given on Friday, September 15. The firm has “Neutral” rating given on Tuesday, August 21 by Citigroup. Morgan Stanley maintained the shares of EL in report on Thursday, November 2 with “Overweight” rating. Morgan Stanley maintained it with “Overweight” rating and $160 target in Thursday, April 5 report. As per Friday, June 2, the company rating was upgraded by Jefferies. The firm has “Outperform” rating by Telsey Advisory Group given on Monday, February 8. Credit Suisse maintained The Estée Lauder Companies Inc. (NYSE:EL) rating on Thursday, May 3. Credit Suisse has “Outperform” rating and $156 target. The rating was maintained by Jefferies on Wednesday, April 19 with “Hold”.

The Estée Lauder Companies Inc. (NYSE:EL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.